These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8426366)
1. Defining structural requirements for neuropeptide Y receptors using truncated and conformationally restricted analogues. Kirby DA; Koerber SC; Craig AG; Feinstein RD; Delmas L; Brown MR; Rivier JE J Med Chem; 1993 Feb; 36(3):385-93. PubMed ID: 8426366 [TBL] [Abstract][Full Text] [Related]
2. Truncated, branched, and/or cyclic analogues of neuropeptide Y: importance of the pancreatic peptide fold in the design of specific Y2 receptor ligands. Reymond MT; Delmas L; Koerber SC; Brown MR; Rivier JE J Med Chem; 1992 Oct; 35(20):3653-9. PubMed ID: 1433176 [TBL] [Abstract][Full Text] [Related]
3. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass. Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586 [TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions. Kirby DA; Boublik JH; Rivier JE J Med Chem; 1993 Nov; 36(24):3802-8. PubMed ID: 8254609 [TBL] [Abstract][Full Text] [Related]
5. Identification of high-potency neuropeptide Y analogues through systematic lactamization. Kirby DA; Britton KT; Aubert ML; Rivier JE J Med Chem; 1997 Jan; 40(2):210-5. PubMed ID: 9003519 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure, and antagonistic properties of des-Asn29[D-Trp28,32]NPY(27-36). Balasubramaniam A; Zhai W; Tao Z; Huang Y; Fischer JE; Eden P; Taylor JE; Kar L; Samarasinghe SD; Johnson ME Peptides; 1996; 17(7):1113-8. PubMed ID: 8959744 [TBL] [Abstract][Full Text] [Related]
7. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. Beck-Sickinger AG; Wieland HA; Wittneben H; Willim KD; Rudolf K; Jung G Eur J Biochem; 1994 Nov; 225(3):947-58. PubMed ID: 7957231 [TBL] [Abstract][Full Text] [Related]
8. Conformational and biological studies of neuropeptide Y analogs containing structural alterations. Fournier A; Gagnon D; Quirion R; Cadieux A; Dumont Y; Pheng LH; St-Pierre S Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286 [TBL] [Abstract][Full Text] [Related]
9. Novel analogues of neuropeptide Y with a preference for the Y1-receptor. Söll RM; Dinger MC; Lundell I; Larhammer D; Beck-Sickinger AG Eur J Biochem; 2001 May; 268(10):2828-37. PubMed ID: 11358498 [TBL] [Abstract][Full Text] [Related]
10. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY. Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351 [TBL] [Abstract][Full Text] [Related]
11. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types. Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M Regul Pept; 1996 Apr; 62(2-3):131-6. PubMed ID: 8795076 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships with neuropeptide Y analogues: a comparison of human Y1-, Y2- and rat Y2-like systems. Cox HM; Tough IR; Ingenhoven N; Beck-Sickinger AG Regul Pept; 1998 Sep; 75-76():3-8. PubMed ID: 9802388 [TBL] [Abstract][Full Text] [Related]
13. The antiparallel pancreatic polypeptide fold in the binding of neuropeptide Y to Y1 and Y2 receptors. Fuhlendorff J; Johansen NL; Melberg SG; Thøgersen H; Schwartz TW J Biol Chem; 1990 Jul; 265(20):11706-12. PubMed ID: 2164012 [TBL] [Abstract][Full Text] [Related]
14. The bioactive conformation of neuropeptide Y analogues at the human Y2-receptor. Rist B; Ingenhoven N; Scapozza L; Schnorrenberg G; Gaida W; Wieland HA; Beck-Sickinger AG Eur J Biochem; 1997 Aug; 247(3):1019-28. PubMed ID: 9288927 [TBL] [Abstract][Full Text] [Related]
15. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine. Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798 [TBL] [Abstract][Full Text] [Related]
16. C-terminal modifications of neuropeptide Y and its analogs leading to selectivity for the mouse brain receptor over the porcine spleen receptor. Krstenansky JL; Owen TJ; Payne MH; Shatzer SA; Buck SH Neuropeptides; 1990 Nov; 17(3):117-20. PubMed ID: 1964720 [TBL] [Abstract][Full Text] [Related]
17. Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor. Rist B; Zerbe O; Ingenhoven N; Scapozza L; Peers C; Vaughan PF; McDonald RL; Wieland HA; Beck-Sickinger AG FEBS Lett; 1996 Sep; 394(2):169-73. PubMed ID: 8843157 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types. Dumont Y; Satoh H; Cadieux A; Taoudi-Benchekroun M; Pheng LH; St-Pierre S; Fournier A; Quirion R Eur J Pharmacol; 1993 Jul; 238(1):37-45. PubMed ID: 8405081 [TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Grandt D; Schimiczek M; Rascher W; Feth F; Shively J; Lee TD; Davis MT; Reeve JR; Michel MC Regul Pept; 1996 Nov; 67(1):33-7. PubMed ID: 8952003 [TBL] [Abstract][Full Text] [Related]
20. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes. Grundemar L; Krstenansky JL; Håkanson R Eur J Pharmacol; 1993 Mar; 232(2-3):271-8. PubMed ID: 8467862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]